We found that the inhibitors of P4H can weaken the function of PTC cells, and P4HA2 expression is closely related to tumor size in patients with PTC, which indicates that P4HA2 is very likely a target for the treatment of PTC. The gene discussed is P4HA2; the disease is neoplasm.